ELP-02

· Elpida Therapeutics SPC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ELP-02, covering 2026-03-03 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Study of Intrathecal ELP-02 for Charcot-Marie-Tooth Disease Type 4J (CMT4J) [Phase 1, Phase 2]